12/08/2011

Report no. 118/2011

Amendment of a significant contract in the subsidiary company “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs that on 9 December 2011 the Company received an annex to the contract concluded by the subsidiary company Powiatowe Centrum Zdrowia sp. z o.o. with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) regarding healthcare services in the scope of hospital treatment for the period from 1 January to 31 December 2011.

Healthcare services referred to in the said annex are provided by the subsidiary company of EMC Instytut Medyczny SA “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary.

The Issuer informed about the contracts concluded by “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary with the Fund Branch concerning rendering services in 2011 in its current reports nos. 17/2011 of 25.01.2011, 23/2011 of 01.02.2011, 26/2011 of 04.02.2011, 34/2011 of 03.03.2011, 40/2011 of 14.03.2011, 59/2011 of 05.04.2011, 63/2011 of 06.05.2011, 66/2011 of 23.05.2011, 71/2011 of 16.06.2011, 78/2011 of 05.07.2011, 82/2011 of  11.07.2011, 84/2011 of 15.07.2011, 92/2011 of 05.08.2011, 94/2011 of 18.08.2011, 97/2011 of 13.09.2011; 106/2011 of  02.11.2011 and  113/2011 of 25.11.2011.

As a result of signing the said annex, the value of the contract with the highest value has changed and it currently amounts to PLN. 8,781,228.00 (an increase by PLN. 73,593.00). The total maximum Fund Branch liability towards the subsidiary company Powiatowe Centrum Zdrowia sp. z o.o. in  Kowary owned by the Issuer currently amounts to PLN. 15,77,818.74 for the period from 1 January to 31 December 2011.

The other material terms of the contract with the highest value made public remain unchanged.

A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital.